The molecular subtype of the primary tumor played a certain role in the engraftment velocity, with mice xenografted with patient samples harboring a BCR::ABL1 translocation demonstrating the lowest mean time to experiment termination (Figure 1F). Here, ABL1 is linked to neoplasm.